Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Helicobacter|April 6, 2019
Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infectionTakahiro Uotani, Kosuke Murakami, Tomohisa Uchida, et al.
International Journal of Hematology|June 1, 2011
Establishment of a simple test for iron absorption from the gastrointestinal tractMasayoshi Kobune, Koji Miyanishi, Kohichi Takada, et al.
Frontiers in Oncology|July 12, 2023
Case Report: Longitudinal monitoring of clonal evolution by circulating tumor DNA for resistance to anti-EGFR antibody in a case of metastatic colorectal cancerTamotsu Sagawa, Yasushi Sato, Masahiro Hirakawa, et al.
World Journal of Gastroenterology|December 28, 2020
Discovery of unique African <i>Helicobacter pylori</i> CagA-multimerization motif in the Dominican RepublicTakaaki Ono, Modesto Cruz, Hiroyuki Nagashima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2022
TNF Receptor-Associated Factor 5 Limits IL-27 Receptor Signaling in CD4<sup>+</sup> T LymphocytesEigo Kawahara, Mitsuki Azuma, Hiroyuki Nagashima, et al.
Respiratory Investigation|September 13, 2025
Efficacy and feasibility of percutaneous needle biopsy in molecular profiling of thoracic cancers via next-generation sequencingYuma Sato, Hiroshi Yokouchi, Keita Tagami, et al.
Immunohorizons|March 12, 2020
TRAF5 Deficiency Ameliorates the Severity of Dextran Sulfate Sodium Colitis by Decreasing TRAF2 Expression in Nonhematopoietic CellsHai The Phung, Hiroyuki Nagashima, Shuhei Kobayashi, et al.
Journal of Medical Microbiology|June 27, 2014
Virulence genes of Helicobacter pylori in the Dominican RepublicSeiji Shiota, Modesto Cruz, José A Jiménez Abreu, et al.
Frontiers in Immunology|July 26, 2023
Hilar/mediastinal and cutaneous drug-induced sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic colorectal cancer: a case reportTamotsu Sagawa, Yasushi Sato, Hiroyuki Nagashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polypsTetsuji Takayama, Hiroyuki Nagashima, Masahiro Maeda, et al.
Pageof 6